Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance-Reference-Cited by-同舟云学术

Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance

Published:2016-11 Issue:4 Volume:167 Page:973-984.e12
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Li Pingping,Liu Shuainan,Lu Min,Bandyopadhyay Gautum,Oh Dayoung,Imamura Takeshi,Johnson Andrew M.F.,Sears Dorothy,Shen Zhufang,Cui Bing,Kong Lijuan,Hou Shaocong,Liang Xiao,Iovino Salvatore,Watkins Steven M.,Ying Wei,Osborn Olivia,Wollam Joshua,Brenner Martin,Olefsky Jerrold M.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference52 articles.

1. Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes;Ahmad;J. Biol. Chem.,2004

2. Galectin-3 activates PPARγ and supports white adipose tissue formation and high-fat diet-induced obesity;Baek;Endocrinology,2015

3. Galectins: a family of animal beta-galactoside-binding lectins;Barondes;Cell,1994

4. Galectins. Structure and function of a large family of animal lectins;Barondes;J. Biol. Chem.,1994

5. Non alcoholic fatty liver disease, hepatic insulin resistance and type 2 diabetes;Birkenfeld;Hepatology,2014

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelial metabolic control of insulin sensitivity through resident macrophages;Cell Metabolism;2024-09

2. Protective effect of Galectin-3 inhibitor against cardiac remodelling in an isoprenaline-induced myocardial infarction in type 2 diabetes;Archives of Physiology and Biochemistry;2024-08-05

3. Exploring galectin-3’s role in predicting mild cognitive impairment in type 2 diabetes and its regulation by miRNAs;Frontiers in Medicine;2024-07-31

4. The Interplay between Obesity and Inflammation;Life;2024-07-08

5. A closer look at Galectin-3: its association with gestational diabetes mellitus revealed by systematic review and meta-analysis;Journal of Diabetes & Metabolic Disorders;2024-07-06